Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$59.69 USD
+1.19 (2.03%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $59.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/8/24 |
---|---|
Current Quarter | -1.02 |
EPS Last Quarter | -1.33 |
Last EPS Surprise | -14.66% |
ABR | 1.44 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.50 |
Next Year | -4.28 |
EPS (TTM) | -5.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.50M | 3.39M | 19.28M | 61.70M |
# of Estimates | 8 | 8 | 10 | 9 |
High Estimate | 51.06M | 20.00M | 54.00M | 225.90M |
Low Estimate | 0.75M | 0.75M | 0.80M | 4.04M |
Year ago Sales | 0.87M | 0.38M | 7.53M | 19.28M |
Year over Year Growth Est. | 1,451.84% | 792.37% | 156.08% | 219.99% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.02 | -1.09 | -4.50 | -4.28 |
# of Estimates | 11 | 10 | 12 | 10 |
Most Recent Consensus | -1.10 | -1.19 | -4.90 | -6.10 |
High Estimate | -0.61 | -0.84 | -4.03 | -2.68 |
Low Estimate | -1.18 | -1.23 | -4.92 | -6.10 |
Year ago EPS | -1.34 | -1.35 | -5.45 | -4.50 |
Year over Year Growth Est. | 23.88% | 19.26% | 17.43% | 4.83% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.02 | -1.09 | -4.50 | -4.28 |
7 Days Ago | -1.02 | -1.09 | -4.50 | -4.28 |
30 Days Ago | -1.02 | -1.09 | -4.50 | -4.28 |
60 Days Ago | -1.08 | -1.11 | -4.55 | -4.17 |
90 Days Ago | -1.16 | -1.11 | -4.50 | -3.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.02 | -1.09 | -4.50 | -4.28 |
Zacks Consensus Estimate | -1.02 | -1.09 | -4.50 | -4.28 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.33 | -1.38 | -1.35 | -1.34 | NA |
Estimate | -1.16 | -1.03 | -0.72 | -1.23 | NA |
Difference | -0.17 | -0.35 | -0.63 | -0.11 | -0.32 |
Surprise | -14.66% | -33.98% | -87.50% | -8.94% | -36.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more